Outset Medical CFO sells shares to cover RSU taxes

Outset Medical, Inc. Chief Financial Officer Renee Gaeta reported an open‑market sale of 17,672 shares of Common Stock at $4.94 per share.

Rhea-AI Filing Summary

Outset Medical, Inc. Chief Financial Officer Renee Gaeta reported an open‑market sale of 17,672 shares of Common Stock at $4.94 per share. According to the disclosure, this was a required “sell to cover” transaction to satisfy tax withholding obligations tied to the vesting of 32,856 RSU-based shares.

The filing notes that the sale does not represent a discretionary trade by the executive. After the transaction, Gaeta directly holds 113,753 shares of Outset Medical Common Stock, indicating she retains a substantial equity stake following the tax‑related sale.

Insider Trade Summary

Net Seller: 17,672 shares

Net Sell 1 txn

Insider Gaeta Renee

Role Chief Financial Officer

Sold 17,672 shs ($87K)

Type	Security	Shares	Price	Value
Sale	Common Stock	17,672	$4.94	$87K

Holdings After Transaction: Common Stock — 113,753 shares (Direct)

Footnotes (1)

1. F1. Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 32,856 shares of Common Stock underlying RSUs granted to the reporting person on June 10, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Key Figures

Shares sold: 17,672 shares Sale price: $4.94 per share Shares after transaction: 113,753 shares +1 more

4 metrics

Shares sold 17,672 shares Open-market sale on 2026-06-03

Sale price $4.94 per share Price for Common Stock sold

Shares after transaction 113,753 shares Direct holdings following sale

RSU vesting amount 32,856 shares Common Stock underlying RSUs vesting

Key Terms

sell to cover, RSUs, tax withholding obligations, Common Stock

4 terms

sell to cover financial

"This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction"

Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.

RSUs financial

"underlying RSUs granted to the reporting person on June 10, 2025"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

tax withholding obligations financial

"Required number of shares sold by the reporting person to cover tax withholding obligations"

Common Stock financial

"32,856 shares of Common Stock underlying RSUs granted to the reporting person"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Outset Medical (OM) disclose for CFO Renee Gaeta?

Outset Medical disclosed that CFO Renee Gaeta sold 17,672 shares of Common Stock at $4.94 per share. The transaction was linked to tax withholding obligations from recently vesting RSUs rather than a discretionary open‑market sale.

Why did Outset Medical CFO Renee Gaeta sell 17,672 OM shares?

The 17,672‑share sale was executed to cover tax withholding obligations from the vesting of 32,856 RSU-based shares. The filing states it was a “sell to cover” transaction and not a discretionary trade by the reporting person.

How many Outset Medical (OM) shares does CFO Renee Gaeta hold after the Form 4 transaction?

Following the reported sale, CFO Renee Gaeta holds 113,753 shares of Outset Medical Common Stock directly. This indicates she continues to maintain a significant ownership position after satisfying tax obligations through the sell‑to‑cover transaction.

What RSU vesting event is related to the Outset Medical CFO’s recent share sale?

The sale relates to the vesting of 32,856 shares of Common Stock underlying RSUs granted to Renee Gaeta on June 10, 2025. Shares were sold to cover associated tax withholding obligations upon this vesting event.

Does the recent Outset Medical insider sale indicate discretionary selling by the CFO?

The filing states the transaction does not represent a discretionary trade by the CFO. It was executed as a required “sell to cover” to satisfy tax withholding obligations linked to the vesting of restricted stock units.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/05/2026 - 06:07 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gaeta Renee

(Last) (First) (Middle)

3052 ORCHARD DRIVE

(Street)

SAN JOSE CALIFORNIA 95134

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Outset Medical, Inc. [ OM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/03/2026		S		17,672(1)	D	$4.94	113,753	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 32,856 shares of Common Stock underlying RSUs granted to the reporting person on June 10, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

	John Brottem For: Renee Gaeta	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)